Published in Medicine (Baltimore) on May 01, 1969
Campylobacter species and Guillain-Barré syndrome. Clin Microbiol Rev (1998) 4.39
Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry (1984) 2.14
Effects of lymphoma on the peripheral nervous system. J R Soc Med (1994) 1.72
Chronic Wallerian degeneration--an in vivo and ultrastructural study. J Anat (1971) 1.55
Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm (2013) 1.43
Autoimmune and virus-induced demyelinating diseases. A review. Am J Pathol (1978) 1.39
Neurological complications of so-called "influenza". A winter study in South-east Wales. Br Med J (1971) 1.35
Autonomic dysfunction in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1981) 1.32
Polyneuritis and herpes zoster. J Neurol Neurosurg Psychiatry (1972) 1.26
Demonstration of antimyelin antibodies by immunofluorescence in Guillain-Barré syndrome. Clin Exp Immunol (1971) 1.26
In vivo demyelination induced by intraneural injection of anti-galactocerebroside serum: a morphologic study. Am J Pathol (1979) 1.25
Peripheral nerve conduction in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry (1977) 1.25
Demyelination and remyelination in recurrent idiopathic polyneuropathy. An electron microscope study. Acta Neuropathol (1971) 1.19
Conduction velocity in the proximal segments of a motor nerve in the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1976) 1.17
Guillain Barré syndrome. Mol Pathol (2001) 1.17
Paralytic ileus as a presenting symptom of Guillain-Barré syndrome. J Neurol (2008) 1.11
Prognostic significance of electrodiagnostic studies in the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1976) 1.07
Patterns and severity of conduction abnormalities in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1991) 1.05
Relapsing corticosteroid-dependent polyneuritis. J Neurol Neurosurg Psychiatry (1970) 1.05
A quantitative electrophysiological study of acute idiopathic polyneuritis. J Neurol Neurosurg Psychiatry (1977) 1.04
Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult. Acta Neuropathol (2010) 1.04
Pathological involvement of primary sensory neurons in Werdnig-Hoffmann disease. Acta Neuropathol (1978) 1.01
Idiopathic polyneuritis: serial studies of nerve and immune functions. J Neurol Neurosurg Psychiatry (1971) 1.01
Hypertension and papilloedema in the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1977) 0.98
Guillain-Barré syndrome: the swine influenza virus vaccine incident in the United States of America, 1976-77: preliminary communication. J R Soc Med (1979) 0.97
Lymphocyte sensitization to nervous tissues and muscle in patients with the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1971) 0.95
Animal model for human disease: Idiopathic polyneuritis, Guillain-Barré Syndrome. Animal model: Coonhound paralysis, idiopathic polyradiculoneuritis of coonhounds. Am J Pathol (1972) 0.95
A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes. J Neurol Neurosurg Psychiatry (1989) 0.94
Experimental allergic neuritis in the dog and its comparison with the naturally occurring disease; coonhound paralysis. Acta Neuropathol (1974) 0.92
Passive transfer of experimental allergic neuritis in Lewis rats by direct injection of sensitized lymphocytes into sciatic nerve. Acta Neuropathol (1972) 0.91
Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. J Neurol Neurosurg Psychiatry (1995) 0.90
Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies. J Neurol Neurosurg Psychiatry (2000) 0.89
Abnormalities of proximal conduction in acute idiopathic polyneuritis: comparison of short latency evoked potentials and F-waves. J Neurol Neurosurg Psychiatry (1984) 0.89
Pathogenesis and treatment of immune-mediated neuropathies. Ther Adv Neurol Disord (2009) 0.88
Clinical aspects of Guillian-Barré syndrome: a review. J R Soc Med (1979) 0.88
Autonomic neuropathy and carcinoma of the lung. Can Med Assoc J (1975) 0.88
Resetting of osmoreceptor response as cause of hyponatraemia in acute idiopathic polyneuritis. Br Med J (1979) 0.87
Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry (1997) 0.87
Sensory evoked potentials in Guillain-Barré polyneuropathy. J Neurol Neurosurg Psychiatry (1984) 0.87
Pseudoaxonal Guillain-Barré syndrome: severe demyelination mimicking axonopathy. A case with pupillary involvement. J Neurol Neurosurg Psychiatry (1992) 0.86
Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1996) 0.86
Adrenomyeloneuropathy. A protracted, pseudosystematic variant of adrenoleukodystrophy. Acta Neuropathol (1980) 0.85
Guillain-Barré syndrome revisited. BMJ (1992) 0.85
Passive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair. J Neurosci (2010) 0.85
Abnormalities of cerebrospinal fluid amino acids in patients with the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1981) 0.84
HLA antigens in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (1990) 0.83
Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention. Acta Neuropathol (2015) 0.83
Erythropoietin enhances nerve repair in anti-ganglioside antibody-mediated models of immune neuropathy. PLoS One (2011) 0.83
Acute polyradiculoneuritis associated with demyelinated plaques in the central nervous system: report of a case. Acta Neuropathol (1985) 0.83
Lymphoma presenting as mononeuritis multiplex. Postgrad Med J (1981) 0.83
Late residua of acute idiopathic polyneuritis. J Neurol Neurosurg Psychiatry (1973) 0.82
Sequence of demyelination-remyelination in Guillain-Barré disease. J Neurol Neurosurg Psychiatry (1983) 0.81
Experimental allergic neuritis: a new experimental approach. J Neurol Neurosurg Psychiatry (1973) 0.81
The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids. Mol Cell Proteomics (2016) 0.80
Coonhound paralysis. Further clinical studies and electron microscopic observations. Acta Neuropathol (1982) 0.80
Inflammatory demyelinating polyradiculitis in a patient with acute disseminated encephalomyelitis (ADEM). J Neurol Neurosurg Psychiatry (1996) 0.80
Systematic reviews of treatment for inflammatory demyelinating neuropathy. J Anat (2002) 0.79
The leakage of serum proteins across the blood-nerve barrier in hereditary and inflammatory neuropathies. An immunohistochemical and morphometric study. Acta Neuropathol (1987) 0.78
Autonomic nerves in experimental allergic neuritis in the rat. Acta Neuropathol (1985) 0.77
Chronic inflammatory demyelinating polyneuropathy in two siblings. J Neurol Neurosurg Psychiatry (1986) 0.77
Changes in lymphocyte subsets in patients with Guillain-Barré syndrome treated with immunoglobulin. BMC Neurol (2014) 0.77
Optic neuritis in the Landry-Guillain-Barré-Strohl syndrome. Br J Ophthalmol (1976) 0.77
Experimental allergic neuritis-like disease in rabbits after injection with influenza vaccines mixed with gangliosides and adjuvants. Infect Immun (1983) 0.77
Sialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury. Exp Neurol (2016) 0.76
P2-peptide induced experimental allergic neuritis: a model to study axonal degeneration. Acta Neuropathol (1991) 0.76
Identification of gene networks and pathways associated with Guillain-Barré syndrome. PLoS One (2012) 0.76
Guillain-Barré syndrome: a century of progress. Nat Rev Neurol (2016) 0.76
Peripheral neuropathy. Br Med J (1970) 0.75
Prognosis of Guillain-Barré syndrome in the African: the Nigerian experience. J Neurol Neurosurg Psychiatry (1973) 0.75
Traditional Chinese medicine Yisui Tongjing relieved neural severity in experimental autoimmune neuritis rat model. Neuropsychiatr Dis Treat (2016) 0.75
Chronic relapsing idiopathic polyneuropathy with primary axonal lesions. J Neurol Neurosurg Psychiatry (1989) 0.75
Multiple sclerosis. Current etiological concepts. Calif Med (1972) 0.75
The landry-guillain-barré strohl syndrome 1859 to 1992 a historical perspective. J Family Community Med (1994) 0.75
Cellular hypersensitivity in Guillain-Barré syndrome. Can Med Assoc J (1974) 0.75
Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis. J Peripher Nerv Syst (2013) 0.75
Idiopathic acute symmetrical polyradiculoneuritis. The Landry-Guillain-Barré-Strohl syndrome. West J Med (1974) 0.75
Factors predicting poor outcome in patients with fulminant Guillaine-Barré syndrome. Ann Indian Acad Neurol (2014) 0.75
Idiopathic polyneuritis. West J Med (1974) 0.75
Significance of lymphocytes and blood vessel changes for edema formation in polyradiculoneuritis. Acta Neuropathol (1988) 0.75
Relapsing Fisher's syndrome. J Neurol Neurosurg Psychiatry (1986) 0.75
Guillain-Barré syndrome: clinical profile and management. Ger Med Sci (2015) 0.75
Are anti-ganglioside antibodies associated with proventricular dilatation disease in birds? PeerJ (2017) 0.75
A Case of Visceral Autonomic Neuropathy Complicated by Guillain-Barre Syndrome Accompanied with Cyclic Vomiting Syndrome-like Disorder in a Child. Pediatr Gastroenterol Hepatol Nutr (2015) 0.75
Dysaesthesias and dysautonomia: a self-limited syndrome of painful dysaesthesias and autonomic dysfunction in childhood. J Neurol Neurosurg Psychiatry (1982) 0.75
Treatment of Guillain-Barré syndrome with anti-T cell monoclonal antibodies. J Neurol Neurosurg Psychiatry (1991) 0.75
Posttraumatic Guillain-Barré Syndrome Immediately Following a Traffic Accident. Korean J Spine (2017) 0.75
Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study. Pilot Feasibility Stud (2017) 0.75
Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification. J Neurol (2016) 0.75
The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci (1968) 5.09
Neurology and psychiatry: closing the great divide. Neurology (2000) 3.68
The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine (Baltimore) (1965) 3.01
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol (1981) 2.53
Induction of tumour immunity with tumour cells treated with iodoacetate. Nature (1966) 2.42
Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology (2007) 2.32
Demyelinative myelopathy in mice induced by the DA virus. J Neurol Sci (1976) 2.20
The role of Schwann cells in the formation of "onion bulbs" found in chronic neuropathies. J Neuropathol Exp Neurol (1967) 2.13
Glue-sniffing neuropathy. Arch Neurol (1975) 1.99
Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain (1970) 1.96
The pathological anatomy of posthemiplegic athetosis. Brain (1975) 1.91
Giant axonal neuropathy--a unique case with segmental neurofilamentous masses. Acta Neuropathol (1972) 1.91
Secretion of a nerve growth factor by primary chick fibroblast cultures. Science (1975) 1.88
Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service. Emerg Med J (2010) 1.88
Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol (1996) 1.85
Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol (1977) 1.84
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
Painful diabetic neuropathy. A morphometric study. Arch Neurol (1976) 1.77
Pure pan-dysautonomia with recovery. Trans Am Neurol Assoc (1969) 1.74
Encephalopathy and peripheral neuropathy following diethylene glycol ingestion. Neurology (2005) 1.73
Multifocal demyelinating neuropathy with persistent conduction block. Neurology (1982) 1.69
The initial lesion in experimental allergic neuritis. A phase and electron microscopic study. J Exp Med (1968) 1.68
Synthesis of nerve growth factor by L and 3T3 cells in culture. Proc Natl Acad Sci U S A (1974) 1.64
Further experience with the syndrome of "normal" pressure hydrocephalus. J Neurosurg (1969) 1.59
Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol (1996) 1.59
CHANGES IN BRAIN VOLUME AND BLOOD CONTENT AFTER EXPERIMENTAL CONCUSSION. Ann Surg (1943) 1.59
The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J Neuroimmunol (1982) 1.57
Pure pan-dysautonomia with recovery. Description and discussion of diagnostic criteria. Brain (1975) 1.56
Giant axonal neuropathy. Pediatrics (1972) 1.53
Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b. Neurology (1995) 1.53
The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations. Contemp Neurol Ser (1971) 1.52
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol (1996) 1.51
Sensory perineuritis. Arch Neurol (1972) 1.51
Ischemic mononeuropathy multiplex associated with diabetes mellitus. Arch Neurol (1968) 1.50
The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 1.49
The acute sensory neuronopathy syndrome: a distinct clinical entity. Ann Neurol (1980) 1.47
Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol (1991) 1.46
Diabetic neuropathy. Ann Neurol (1984) 1.44
Idiopathic polyneuritis after surgery. Arch Neurol (1968) 1.43
Physiologic-pathologic correlation in Guillain-Barré syndrome in children. Neurology (2000) 1.43
Schwann cell proliferation in developing mouse sciatic nerve. A radioautographic study. J Cell Biol (1967) 1.41
Breathing patterns during spontaneous speech. J Speech Hear Res (1995) 1.40
Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis (2001) 1.40
Hemangioblastoma of the spinal cord. Review and report of five cases. Arch Neurol (1976) 1.39
Multiple sclerosis: additional thoughts. J Neurol Sci (1992) 1.38
Secretion of a nerve growth factor by mouse neuroblastoma cells in culture. Proc Natl Acad Sci U S A (1975) 1.36
Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. N Engl J Med (1976) 1.36
The reticulum cell sarcoma--microglioma group of brain tumours. A consideration of their clinical features and therapy. Brain (1972) 1.36
S-100 protein in human chondrocytes. Nature (1982) 1.35
Cerebro-hepato-renal syndrome of Zellweger: an inherited disorder of neuronal migration. Acta Neuropathol (1972) 1.35
Interferon beta in multiple sclerosis. Neurology (1993) 1.35
Duration of synthesis phase in neuilemma cells in mouse sciatic nerve during degeneration. Exp Neurol (1970) 1.34
Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol (1996) 1.34
Studies on the mechanism of action of nerve growth factor. Proc Natl Acad Sci U S A (1972) 1.32
Cervical internal carotid artery dissecting hemorrhage: diagnosis using MR. Radiology (1986) 1.32
Pathogenesis of lead encephalopathy. Uptake of lead and reaction of brain capillaries. Arch Neurol (1974) 1.31
Biometric analyses of normal skeletal muscle. Acta Neuropathol (1971) 1.31
Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. N Engl J Med (1968) 1.30
Functional strength training in cerebral palsy: a pilot study of a group circuit training class for children aged 4-8 years. Clin Rehabil (2003) 1.30
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol (1999) 1.28
Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature (1980) 1.28
Cell-mediated demyelination of peripheral nerve in tissue culture. Lab Invest (1969) 1.28
Experimental autonomic neuropathy: an immunologically induced disorder of reflex vasomotor function. J Neurol Neurosurg Psychiatry (1965) 1.26
Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum. Lab Invest (1978) 1.25
Suppressor cell function in multiple sclerosis. Ann Immunol (Paris) (1978) 1.22
Hereditary sensory neuropathy. A clinical and ultrastructural study. J Neurol Sci (1970) 1.22
Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19
Variability and consistency in speech breathing during reading: lung volumes, speech intensity, and linguistic factors. J Speech Hear Res (1994) 1.18
Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol (1979) 1.17
Distal neuropathy in experimental diabetes mellitus. Ann Neurol (1980) 1.15
Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference. Neurology (1996) 1.15
Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology (1998) 1.14
Renaut bodies. A forgotten endoneurial structure. J Neuropathol Exp Neurol (1973) 1.14
Pain due to peripheral nerve damage: an hypothesis. Neurology (1984) 1.14
The nervous system diseases associated with varicella. A critical commentary with additional notes on the syndrome of acute encephalopathy with fatty hepatosis. Acta Neurol Scand (1970) 1.13
Recent observations on normal pressure hydrocephalus. Schweiz Arch Neurol Neurochir Psychiatr (1975) 1.13
Circulating suppressor cells in man as a function of age. Clin Immunol Immunopathol (1978) 1.13
Brainstem auditory hallucinosis. Neurology (1986) 1.13
The ultrastructural morphology of the muscle fiber in myotonic dystrophy. Acta Neuropathol (1968) 1.11
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci (2001) 1.10
Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve (2009) 1.09
Changes in concanavalin A capping of human lymphocytes with age. Mech Ageing Dev (1980) 1.09
Fabry disease: impaired autonomic function. Neurology (1982) 1.09
Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis. Ann Neurol (1981) 1.08
Cell-mediated immunity in polymyositis. Creatine phosphokinase release from muscle cultures. Arch Neurol (1974) 1.07
Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. N Engl J Med (1983) 1.05
A monoclonal antibody against human T suppressor lymphocytes binds specifically to the surface of cultured oligodendrocytes. Nature (1982) 1.05
The significance of giant vacuolation of endoneurial fibroblasts. Acta Neuropathol (1971) 1.05
Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis. J Neurol Sci (1974) 1.05
Monoclonal antibodies against purified nicotinic acetylcholine receptor. Biochem Biophys Res Commun (1979) 1.04